Cathay Biotech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	488.96	366.52	553.27	594.72
Depreciation & Amortization	315.92	285.72	265.12	168.54
Other Amortization	9.54	3.88	4.68	3.68
Loss (Gain) From Sale of Assets	-0.4	0.01	-0.05	-
Asset Writedown & Restructuring Costs	0.04	4.93	36.22	10.69
Loss (Gain) From Sale of Investments	8.95	7.82	3.71	-16.3
Provision & Write-off of Bad Debts	3.34	-6.27	-	-
Other Operating Activities	72.6	76.88	-3.57	25.36
Change in Accounts Receivable	-246.25	-320.06	24.8	-224.95
Change in Inventory	198.51	78.3	-418.06	-282.62
Change in Accounts Payable	22.48	133.66	355.46	310.02
Change in Other Net Operating Assets	-1.26	8.65	18.18	6.47
Operating Cash Flow	820.93	569.45	803.67	578.69
Operating Cash Flow Growth	44.16%	-29.14%	38.88%	12.37%
Capital Expenditures	-843.31	-1,570	-4,198	-1,459
Sale of Property, Plant & Equipment	20.25	142.01	0.14	-
Investment in Securities	-	-101.04	-	1,320
Other Investing Activities	-	-30	-	28.42
Investing Cash Flow	-823.06	-1,559	-4,198	-110.76
Long-Term Debt Issued	1,889	937.02	1,126	798.08
Long-Term Debt Repaid	-1,570	-289.77	-740	-55
Total Debt Repaid	-1,570	-289.77	-740	-55
Net Debt Issued (Repaid)	319.26	647.25	386.47	743.08
Issuance of Common Stock	-	4.17	4.52	-
Repurchase of Common Stock	-28.93	-31.52	-94.67	-
Common Dividends Paid	-140.83	-137.75	-206.85	-339.63
Dividends Paid	-140.83	-137.75	-206.85	-339.63
Other Financing Activities	-	-744.31	314.41	2,584
Financing Cash Flow	149.49	-262.16	403.88	2,987
Foreign Exchange Rate Adjustments	24.82	40.22	59.98	-9.19
Net Cash Flow	172.19	-1,211	-2,931	3,446
Free Cash Flow	-22.38	-1,000	-3,395	-880.49
Free Cash Flow Margin	-0.76%	-47.32%	-139.06%	-37.25%
Free Cash Flow Per Share	-0.04	-1.72	-5.83	-1.51
Cash Income Tax Paid	229.15	90.88	-281.56	-12.97
Levered Free Cash Flow	-418.14	-567.98	-3,302	-1,301
Unlevered Free Cash Flow	-400.99	-547.87	-3,290	-1,290
Change in Working Capital	-78.01	-170.04	-55.7	-208

Source: S&P Global Market Intelligence. Standard template. Financial Sources.